MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$377.995M
Unrealized gain on
investments
$0.156M
Net loss
-$377.737M
Foreign currency
translation adjustment
-$0.414M
Income tax (benefit)
provision
-$0.079M
Interest income
$12.151M
Other income, net
$0.417M
Loss before income
taxes
-$377.816M
Total other income
(expense), net
$5.241M
License and
collaboration revenue
$10M
Interest expense on
royalty obligation
$7.327M
Loss from operations
-$383.057M
Total revenue
$10M
Total operating
expenses
$393.057M
Acquired in-process
research and development
$171.672M
Research and development
$168.063M
General and
administrative
$53.322M
Back
Back
Income Statement
source: myfinsight.com
Zenas BioPharma, Inc. (ZBIO)
Zenas BioPharma, Inc. (ZBIO)